{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:04:57Z","timestamp":1770656697732,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ncl.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T18:27:15Z","timestamp":1595269635000},"page":"481-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Skeletal Muscle Channelopathies"],"prefix":"10.1016","volume":"38","author":[{"given":"Vinojini","family":"Vivekanandam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinki","family":"Munot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ncl.2020.04.003_bib1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","article-title":"Prevalence study of genetically defined skeletal muscle channelopathies in England","volume":"80","author":"Horga","year":"2013","journal-title":"Neurology"},{"issue":"4983","key":"10.1016\/j.ncl.2020.04.003_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","article-title":"Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene","volume":"250","author":"Fontaine","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ncl.2020.04.003_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(91)90374-8","article-title":"Identification of a mutation in the gene causing hyperkalemic periodic paralysis","volume":"67","author":"Ptacek","year":"1991","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ncl.2020.04.003_bib4","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1212\/WNL.53.9.1932","article-title":"A\u00a0novel sodium channel mutation in a family with hypokalemic periodic paralysis","volume":"53","author":"Bulman","year":"1999","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2020.04.003_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features","volume":"35","author":"Tawil","year":"1994","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2020.04.003_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1651-2227.1971.tb06990.x","article-title":"Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?","volume":"60","author":"Andersen","year":"1971","journal-title":"Acta Paediatr Scand"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2020.04.003_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/awp294","article-title":"The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment","volume":"133","author":"Matthews","year":"2010","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ncl.2020.04.003_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/mus.20923","article-title":"Differential diagnosis of myotonic disorders","volume":"37","author":"Miller","year":"2008","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ncl.2020.04.003_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","article-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","volume":"56","author":"Fournier","year":"2004","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2020.04.003_bib10","first-page":"1731","article-title":"High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany","volume":"255","author":"Suominen","year":"2008","journal-title":"J\u00a0Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2020.04.003_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.nmd.2014.06.439","article-title":"Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia","volume":"24","author":"Furby","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"12","key":"10.1016\/j.ncl.2020.04.003_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11940-016-0434-1","article-title":"Myotonic dystrophy type 1 management and therapeutics","volume":"18","author":"Smith","year":"2016","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2020.04.003_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1212\/WNL.0b013e3181fe72d7","article-title":"Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1","volume":"76","author":"Groh","year":"2011","journal-title":"Neurology"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2020.04.003_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/brain\/awh639","article-title":"The primary periodic paralyses: diagnosis, pathogenesis and treatment","volume":"129","author":"Venance","year":"2006","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ncl.2020.04.003_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ejhg.5201218","article-title":"Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype","volume":"12","author":"Duno","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ncl.2020.04.003_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jpeds.2017.05.081","article-title":"Skeletal muscle channelopathies: rare disorders with common pediatric symptoms","volume":"188","author":"Matthews","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"21","key":"10.1016\/j.ncl.2020.04.003_bib17","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/CIRCULATIONAHA.104.472498","article-title":"Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype","volume":"111","author":"Zhang","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ncl.2020.04.003_bib18","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1468-1331.2012.03751.x","article-title":"Measuring quality of life impairment in skeletal muscle channelopathies","volume":"19","author":"Sansone","year":"2012","journal-title":"Eur J Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:29Z","timestamp":1760005049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0733861920300384"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.04.003","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Muscle Channelopathies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}